HANMIPHARMHANMIPHARMHANMIPHARM

HANMIPHARM

No trades
See on Supercharts
Market capitalization
‪4.02 T‬KRW
11 500KRW
‪146.23 B‬KRW
‪1.49 T‬KRW
‪6.31 M‬
Beta (1Y)
0.77

About HANMIPHARM

CEO
Jong-Yoon Lim
Headquarters
Hwaseong-si
Employees (FY)
‪2.34 K‬
Founded
1973
ISIN
KR7128940004
FIGI
BBG000QKWSN4
Hanmi Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products. Its products include medicines for high blood pressure, hyperlipidemia, reflux esophagitis, and cerebrovascular disease. The company was founded by Lim Sung-Gi on June 15, 1973 and is headquartered in Hwaseong-si, South Korea.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 128940 is 301 000 KRW — it has decreased by 1.63% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange HANMIPHARM stocks are traded under the ticker 128940.
HANMIPHARM is going to release the next earnings report on May 1, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for HANMIPHARM has a max estimate of 507 000 KRW and a min estimate of 370 000 KRW.
128940 earnings for the last quarter are ‪1.40 K‬ KRW whereas the estimation was ‪1.45 K‬ KRW which accounts for −3.06% surprise. Estimated earnings for the next quarter are ‪1.53 K‬ KRW. See more details about HANMIPHARM earnings.
HANMIPHARM revenue for the last quarter amounts to ‪364.60 B‬ KRW despite the estimated figure of ‪368.14 B‬ KRW. In the next quarter revenue is expected to reach ‪400.84 B‬ KRW.
Yes, you can track HANMIPHARM financials in yearly and quarterly reports right on TradingView.
Like other stocks, 128940 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HANMIPHARM stock right from TradingView charts — choose your broker and connect to your account.
128940 reached its all-time high on Nov 10, 2015 with the price of 699 500 KRW, and its all-time low was 34 000 KRW and was reached on May 24, 2012.
See other stocks reaching their highest and lowest prices.
As of Apr 16, 2024, the company has ‪2.34 K‬ employees. See our rating of the largest employees — is HANMIPHARM on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HANMIPHARM EBITDA is ‪323.34 B‬ KRW, and current EBITDA margin is 21.69%. See more stats in HANMIPHARM financial statements.